Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis

Abstract

Objective Temporomandibular joint (TMJ) involvement is common in Juvenile Idiopathic Arthritis (JIA). Dexamethasone iontophoresis (DIP) uses low-grade electric currents for transdermal dexamethasone delivery into deeper anatomic structures. The purpose of this study was to assess the safety and effectiveness of DIP for the treatment of TMJ involvement in JIA, and to delineate variables that are associated with improvement after DIP. Methods Medical records of all JIA patients who underwent DIP for TMJ involvement at a larger tertiary pediatric rheumatology center from 1997 to 2011 were reviewed. DIP was performed using a standard protocol. The effectiveness of DIP was assessed by comparing the maximal inter-incisor opening (MIOTMJ) and the maximal lateral excursion (MLETMJ) before and after treatment. Results Twenty-eight patients (ages 2– 21 years) who received an average of eight DIP treatment sessions per involved TMJ were included in the analysis. Statistically significant improvement in the median MIOTMJ (p< 0.0001) was observed in 68%. The median MLETMJ (p= 0.03) improved in 69%, and resolution of TMJ pain occurred in 73% of the patients who had TMJ pain at baseline. Side effects of DIP were transient site erythema (86%), skin blister (4%), and metallic taste (4%). Improvement in TMJ range of motion from DIP is associated with lower MIOTMJ, lower MLETMJ, and absence of TMJ crepitus at baseline. Conclusion In this pilot study DIP appeared to be an effective and safe initial treatment of TMJ involvement in JIA, especially among patients with decreased TMJ measurements. Prospective controlled studies are needed.

Delivery of neostigmine and glycopyrrolate by iontophoresis: a nonrandomized study in individuals with spinal cord injury

“…ION has achieved clinical relevance in treatment of musculoskeletal conditions, such as fasciitis, bursitis and epicondylitis [ref. ( 13 )]. ION approach has also been approved by the FDA for the treatment of migraines using sumatriptan [ref.…”

Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance

“…Incorporation of dexamethasone into PDMAEMA-PLGA NPs slightly decreased the surface charges of the NPs to +32.3 ± 0.4 mV. Since dexamethasone in the form of a solution is composed of negatively charged ions [18], the reduced charges of PDMAEMA-PLGA NPs incorporated with dexamethasone may be due to neutralization of the charge by the low amount of dexamethasone that interacted with the positive charges of PDMAEMA (Figure 1B and in the Section 4). In the TGA and DTA traces of PDMAEMA-PLGA NPs (Figure S1A,B), the materials showed combined characteristics of PDMAEMA, PLGA, and PVA with no significant changes in thermal stability of individual polymers.…”

Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?

“…An alternative method of delivering CS to the TMJ was introduced by Mina et al [ 67 ]. This procedure consists of transdermal application of the drug, which is forced into deeper tissues through application of an electrical current.…”